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elmut Baumgartner, MD,†
atherine M. Otto, MD‡
uenster, Germany; and Seattle, Washington
ortic stenosis (AS) is the most frequent indication for
alve replacement in Europe and North America, and
orrect diagnosis and timing of surgery are critical.
lthough it is evident that patients with symptoms
ttributable to severe AS require prompt valve replace-
ent, there remain some unresolved issues in clinical
ecision making (1).
First, symptomatic AS patients occasionally do not fulfill
he criteria of severe stenosis, yet have no cause for symp-
oms other than apparently moderate AS. In other patients,
urrently recommended diagnostic criteria may be inconsis-
ent: for example, valve area is in the severe range but
ressure gradient is low, even with normal left ventricular
LV) function (2). These cases raise the question of whether
he current criteria used to define severe AS are optimal or
hether we need to do more than simply look at valve areas,
ransvalvular velocities, and pressure gradients (3).
See page 1003
Second, when to operate on asymptomatic patients with
emodynamically severe AS remains a controversial issue.
lthough the risk of surgery and the long-term risks of a
rosthetic valve may not justify valve replacement in all of
hese patients, some of them are at increased risk of adverse
vents and may indeed benefit from elective surgery. Thus,
isk stratification of asymptomatic severe AS remains an
nresolved issue.
In this issue of the Journal, Hachicha et al. (4) present
nteresting new data with respect to both issues. This group
reviously proposed the new parameter of valvuloarterial
mpedance (Zva) as a more robust descriptor of AS hemo-
ynamics and a better predictor of LV dysfunction, com-
ared with standard measures of stenosis severity (5). Now,
ased on a retrospective analysis of 544 consecutive patients
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From †The Adult Congenital and Valvular Heart Disease Center, University ofc
uenster, Muenster, Germany; and the ‡Division of Cardiology, University of
ashington School of Medicine, Seattle, Washington.ith at least moderate AS, they show that Zva is a strong
ndependent predictor of clinical outcome.
The Zva is calculated by dividing the estimated LV
ystolic pressure (systolic arterial pressure  mean transval-
ular gradient) by stroke volume index; thus Zva represents
he pressure “cost” (in mm Hg) for each milliliter of blood
umped by the LV during systole, indexed for body surface
rea. This index accounts for the fact that reduced arterial
ompliance is a frequent finding in patients with AS and
ndependently contributes to increased afterload (6). In-
eed, the LV faces a double load, valvular and arterial,
articularly in hypertensive patients, which comprise about
0% of AS patients in current clinical practice (7).
It is a reasonable hypothesis that symptoms and LV
ysfunction, as well as adverse events, may better correlate
ith this measure of global LV burden compared with
tandard measures of AS severity. For example, a high Zva
ay explain why a patient with moderate AS is symptom-
tic. More importantly, a high Zva may confirm severe AS in
patient with a small valve area but low gradient despite a
ormal ejection fraction. Such patients are not uncommon
n the elderly AS population, frequently presenting with LV
ypertrophy and a history of hypertension but a normal or
seudo-normal blood pressure. Closer evaluation may iden-
ify a low stroke volume despite normal ejection fraction.
his entity, only recently recognized, is called paradoxical
ow-flow AS. Such patients may be misdiagnosed with
onsevere AS; recent reports indicate a poor outcome
ithout valve replacement (8). Paradoxical low-flow AS
ay be one of the reasons for the worse outcome of patients
ith high Zva in the present study.
Some questions remain unanswered in this publication
4). Cause of death could not reliably be identified in all
atients; the analysis of mortality was retrospective, often
ased on death certificates. Furthermore, little is known
bout the disease course and patient management after the
ndex echocardiogram, including symptom onset and appro-
riateness of medical therapy for hypertension. The high
ortality rate with medical therapy is surprising, suggesting
hat some patients may have developed symptoms or other
ndications for valve replacement. In particular, it remains
nknown how many patients were not referred to surgery
ecause of advanced age, comorbidities, or failure to report
ymptoms to the physician.
In addition, Zva has some intrinsic limitations. Although
eflecting global LV burden, Zva does not account separately
or the valvular versus arterial component. A patient with
evere hypertension, reduced cardiac output, and only mild AS
ay present with the same Zva as a patient with severe AS.
hereas the first requires intensive blood pressure control, the
econd requires valve replacement. Thus, the individual com-
onents of valvuloarterial impedance are critical for patient
anagement rather than the proposed new parameter itself.
nother limitation of Zva is that pressure recovery is notonsidered in this measurement: Zva significantly overesti-
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September 8, 2009:1012–3 Aortic Stenosis Severityates total LV load in patients with a relatively small aorta
i.e.,30 mm diameter) because kinetic energy is converted
ack into potential energy with a significant increase in
ortic pressure distal to the stenosis (9). In this case, Zva
verestimates the LV load. In addition, Zva is not a stable
arameter but varies with spontaneous or treatment-related
lood pressure changes. The clinical consequence of this
ffect is evident by simply looking at the components
equired for Zva calculation. For example, a symptomatic
atient with nonsevere AS, based on valve area and velocity/
radient measurement, but with hypertension should have
dequate blood pressure control before calculation of Zva.
Instead of introducing a new parameter such as Zva, with
ts own limitations, we propose an integrated approach to
valuation of the patient with AS that not only incorporates
tandard parameters of stenosis severity (aortic jet velocity,
ean pressure gradient, and valve area), symptom status,
nd LV function but also carefully considers stroke volume
nd blood pressure for correct data interpretation and
atient management (3). However, the concept of Zva, as
llustrated in this study by Hachicha et al. (4), highlights
mportant messages for assessment and treatment of AS:
. Arterial hypertension requires special attention in AS.
Hypertension is frequently present in AS patients, par-
ticularly in elderly patients, and increases the already-
high load faced by the LV. Hypertension also is likely to
worsen clinical outcome. Appropriate blood pressure
control is critical even though management is compli-
cated by the limited data on antihypertensive treatment
in this patient group, physician fear of excessive blood
pressure lowering in AS patients, and the need for slow
and careful dose titration, especially with increasing AS
severity.
. Paradoxical low-flow AS, a relatively low transvalvular
gradient despite a normal ejection fraction, should be
considered, especially in elderly AS patients with a
history of hypertension and a small valve area. Although
these patients may benefit from valve replacement, they
may be misdiagnosed as having nonsevere AS.
. Symptomatic patients with AS who are found to have
moderate AS, defined by valve area and gradient, with
concurrent high blood pressure (or high valvuloarterial
impedance) require antihypertensive treatment, with re-
K
cpeat evaluation of AS severity when normotensive.
Whether these patients should have early surgery when
symptoms persist despite treatment requires further
research.
We now recognize that a complete description of the
emodynamics of aortic valve obstruction includes consid-
ration of the LV response to pressure overload, the severity
f valve narrowing, and the total systemic vascular load.
owever, in everyday clinical practice we can continue to
ely on currently recommended measures of stenosis severity
s long as we also consider blood pressure and cardiac
utput.
eprint requests and correspondence: Dr. Catherine M. Otto,
ivision of Cardiology, Box 356422, University of Washington,
eattle, Washington 98195. E-mail: cmotto@u.washington.edu.
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